India's Akums Drugs and Pharmaceuticals gains on quarterly profit rise
** Shares of Akums Drugs and Pharmaceuticals AKUM.NS rise 3.5% to 497 rupees ** Drugmaker posts 5.5% Y/Y rise in June-qtr consol net profit; consol rev from ops rises 0.5% Y/Y ** AKUM rated "strong buy" by 3 analysts on average; median target price is 710 rupees – data compiled by LSEG ** Stock down 22% YTD (Reporting by Rudra Pratap Singh in Bengaluru) ((rudrapratap.singh@thomsonreuters.com))
Recent news on Akums Drugs and Pharmaceuticals
See all newsIndia's Akums Drugs and Pharmaceuticals gains on higher quarterly profit
Brief: Akums Drugs And Pharmaceuticals Resumes 100% Operations At Uttarakhand Sites From May 18, 2026
Brief: Akums Drugs And Pharmaceuticals Reports Disruption At Haridwar Manufacturing Sites Due To Labour Unrest
Brief: Akums Drugs And Pharmaceuticals March-Quarter Consol Net Profit 846.1 Million Rupees
Brief: Akums Drugs Announces Execution Of Lease Deed For Uttarakhand Land